AMRIZE LTD (AMRZ) Fundamental Analysis & Valuation

NYSE:AMRZ • CH1430134226

Current stock price

55.189 USD
-0.93 (-1.66%)
Last:

This AMRZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AMRZ Profitability Analysis

1.1 Basic Checks

  • AMRZ had positive earnings in the past year.
AMRZ Yearly Net Income VS EBIT VS OCF VS FCFAMRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • With a Return On Assets value of 5.30%, AMRZ perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
  • The Return On Equity of AMRZ (9.88%) is comparable to the rest of the industry.
  • AMRZ has a Return On Invested Capital of 7.43%. This is comparable to the rest of the industry: AMRZ outperforms 53.85% of its industry peers.
Industry RankSector Rank
ROA 5.3%
ROE 9.88%
ROIC 7.43%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMRZ Yearly ROA, ROE, ROICAMRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • AMRZ has a Profit Margin (10.89%) which is in line with its industry peers.
  • With a decent Operating Margin value of 18.16%, AMRZ is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • AMRZ has a worse Gross Margin (26.23%) than 69.23% of its industry peers.
Industry RankSector Rank
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMRZ Yearly Profit, Operating, Gross MarginsAMRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AMRZ Health Analysis

2.1 Basic Checks

  • AMRZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for AMRZ remains at a similar level compared to 1 year ago.
  • AMRZ has a better debt/assets ratio than last year.
AMRZ Yearly Shares OutstandingAMRZ Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 100M 200M 300M 400M 500M
AMRZ Yearly Total Debt VS Total AssetsAMRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • AMRZ has an Altman-Z score of 2.56. This is not the best score and indicates that AMRZ is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AMRZ has a Altman-Z score of 2.56. This is comparable to the rest of the industry: AMRZ outperforms 46.15% of its industry peers.
  • A Debt/Equity ratio of 0.45 indicates that AMRZ is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.45, AMRZ is in line with its industry, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 2.56
ROIC/WACC0.69
WACC10.79%
AMRZ Yearly LT Debt VS Equity VS FCFAMRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.45 indicates that AMRZ should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.45, AMRZ is doing worse than 69.23% of the companies in the same industry.
  • AMRZ has a Quick Ratio of 1.45. This is a bad value and indicates that AMRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.97, AMRZ is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.97
AMRZ Yearly Current Assets VS Current LiabilitesAMRZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AMRZ Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.26% over the past year.
  • AMRZ shows a small growth in Revenue. In the last year, the Revenue has grown by 0.23%.
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 11.82% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.37% on average over the next years.
EPS Next Y3.63%
EPS Next 2Y11.4%
EPS Next 3Y11.48%
EPS Next 5Y11.82%
Revenue Next Year3.49%
Revenue Next 2Y3.98%
Revenue Next 3Y4.48%
Revenue Next 5Y4.37%

3.3 Evolution

AMRZ Yearly Revenue VS EstimatesAMRZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
AMRZ Yearly EPS VS EstimatesAMRZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

2

4. AMRZ Valuation Analysis

4.1 Price/Earnings Ratio

  • AMRZ is valuated rather expensively with a Price/Earnings ratio of 24.00.
  • AMRZ's Price/Earnings ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 61.54% of the companies in the same industry.
  • AMRZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.61.
  • A Price/Forward Earnings ratio of 19.30 indicates a rather expensive valuation of AMRZ.
  • Based on the Price/Forward Earnings ratio, AMRZ is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
  • AMRZ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24
Fwd PE 19.3
AMRZ Price Earnings VS Forward Price EarningsAMRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 61.54% of the companies in the same industry are more expensive than AMRZ, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.92
AMRZ Per share dataAMRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMRZ does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.6
PEG (5Y)N/A
EPS Next 2Y11.4%
EPS Next 3Y11.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMRZ Dividend Analysis

5.1 Amount

  • No dividends for AMRZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMRZ Fundamentals: All Metrics, Ratios and Statistics

AMRIZE LTD

NYSE:AMRZ (3/26/2026, 1:50:06 PM)

55.189

-0.93 (-1.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-17
Earnings (Next)N/A
Inst Owners53.63%
Inst Owner ChangeN/A
Ins Owners7.23%
Ins Owner Change15.87%
Market Cap30.54B
Revenue(TTM)11.70B
Net Income(TTM)1.27B
Analysts77.78
Price Target60.38 (9.41%)
Short Float %1.57%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.79%
Min EPS beat(2)-33.5%
Max EPS beat(2)3.92%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)-1.97%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.44%
EPS NY rev (1m)1.22%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)-1.88%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 24
Fwd PE 19.3
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 2.37
P/tB 14.23
EV/EBITDA 11.92
EPS(TTM)2.3
EY4.17%
EPS(NY)2.86
Fwd EY5.18%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.15
BVpS23.31
TBVpS3.88
PEG (NY)6.6
PEG (5Y)N/A
Graham Number34.73
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 9.88%
ROCE 10.18%
ROIC 7.43%
ROICexc 7.72%
ROICexgc 16.16%
OM 18.16%
PM (TTM) 10.89%
GM 26.23%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 1.93
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.97
Altman-Z 2.56
F-ScoreN/A
WACC10.79%
ROIC/WACC0.69
Cap/Depr(3y)69.39%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)137.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y3.63%
EPS Next 2Y11.4%
EPS Next 3Y11.48%
EPS Next 5Y11.82%
Revenue 1Y (TTM)0.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.49%
Revenue Next 2Y3.98%
Revenue Next 3Y4.48%
Revenue Next 5Y4.37%
EBIT growth 1Y13.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.92%
EBIT Next 3Y19.13%
EBIT Next 5Y13.72%
FCF growth 1Y16.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.08%
OCF growth 3YN/A
OCF growth 5YN/A

AMRIZE LTD / AMRZ Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

ChartMill assigns a fundamental rating of 2 / 10 to AMRZ.


What is the valuation status of AMRIZE LTD (AMRZ) stock?

ChartMill assigns a valuation rating of 2 / 10 to AMRIZE LTD (AMRZ). This can be considered as Overvalued.


What is the profitability of AMRZ stock?

AMRIZE LTD (AMRZ) has a profitability rating of 2 / 10.


What is the financial health of AMRIZE LTD (AMRZ) stock?

The financial health rating of AMRIZE LTD (AMRZ) is 3 / 10.